A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC
- 9 May 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 103 (19), 7494-7499
- https://doi.org/10.1073/pnas.0602217103
Abstract
G3139, an 18-mer phosphorothioate antisense oligonucleotide targeted to the initiation codon region of the Bcl-2 mRNA, can induce caspase-dependent apoptosis via the intrinsic mitochondrial pathway in 518A2 and other melanoma cells. G3139-mediated apoptosis appears to be independent of its ability to down-regulate the expression of Bcl-2 protein, because the release of mitochondrial cytochrome c precedes in time the down-regulation of Bcl-2 protein expression. In this study, we demonstrate the ability of G3139 and other phosphorothioate oligonucleotides to bind directly to mitochondria isolated from 518A2 cells. Furthermore, we show that this interaction leads to the release of cytochrome c in the absence of a mitochondrial membrane permeability transition. Our data further demonstrate that there is an interaction between G3139 and VDAC, a protein that can facilitate the physiologic exchange of ATP and ADP across the outer mitochondrial membrane. Evidence from the electrophysiologic evaluation of VDAC channels reconstituted into phospholipid membranes demonstrates that G3139 is capable of producing greatly diminished channel conductance, indicating a closed state of the VDAC. This effect is oligomer length-dependent, and the ability of phosphorothioate homopolymers of thymidine of variable lengths to cause the release of cytochrome c from isolated mitochondria of 518A2 melanoma cells can be correlated with their ability to interact with VDAC. Because it has been suggested that the closure of VDAC leads to the opening of another outer mitochondrial membrane channel through which cytochrome c can transit, thus initiating apoptosis, it appears that VDAC may be an important pharmacologic target of G3139.Keywords
This publication has 40 references indexed in Scilit:
- Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cellsMolecular Cancer Therapeutics, 2005
- Chemotherapy: targeting the mitochondrial cell death pathwayOncogene, 2002
- Ceramide Channels Increase the Permeability of the Mitochondrial Outer Membrane to Small ProteinsOnline Journal of Public Health Informatics, 2002
- Oblimersen Bcl-2 Antisense: Facilitating Apoptosis in Anticancer TreatmentAntisense and Nucleic Acid Drug Development, 2002
- Cytochrome c release from mitochondria proceeds by a two-step processProceedings of the National Academy of Sciences of the United States of America, 2002
- Bcl-x Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial MembraneOnline Journal of Public Health Informatics, 2001
- Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor modelInternational Journal of Cancer, 2001
- Chemosensitisation of malignant melanoma by BCL2 antisense therapyThe Lancet, 2000
- Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c releaseCell Death & Differentiation, 2000
- Electrophysiological Study of a Novel Large Pore Formed by Bax and the Voltage-dependent Anion Channel That Is Permeable to Cytochrome cPublished by Elsevier BV ,2000